Similar proportions of women lose bone mineral density with raloxifene or alendronate treatment.

[1]  S. Cummings,et al.  Risk of fracture among women who lose bone density during treatment with alendronate. The Fracture Intervention Trial , 2005, Osteoporosis International.

[2]  Richard Eastell,et al.  Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[3]  S. Greenspan,et al.  Once-weekly alendronate 70 mg and raloxifene 60 mg daily in the treatment of postmenopausal osteoporosis* , 2004, Menopause.

[4]  P. Geusens,et al.  Alendronate produces greater effects than raloxifene on bone density and bone turnover in postmenopausal women with low bone density: results of EFFECT (EFficacy of FOSAMAX® versus EVISTA®Comparison Trial) International 1 , 2004, Journal of internal medicine.

[5]  C. Cooper,et al.  Relationship Between Changes in Bone Mineral Density and Fracture Risk Reduction With Antiresorptive Drugs: Some Issues With Meta‐Analyses , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[6]  E. Lewiecki.  Nonresponders to osteoporosis therapy. , 2003, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[7]  R. Heaney,et al.  Is the paradigm shifting? , 2003, Bone.

[8]  S. Cummings,et al.  Clinical use of bone densitometry: scientific review. , 2002, JAMA.

[9]  L. Lenchik,et al.  What is the role of serial bone mineral density measurements in patient management? , 2002, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[10]  S. Bonnick.  Current controversies in bone densitometry , 2002, Current opinion in rheumatology.

[11]  J. Kanis,et al.  Diagnosis of osteoporosis and assessment of fracture risk , 2002, The Lancet.

[12]  M. Hochberg,et al.  Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  O. Johnell,et al.  Additive effects of raloxifene and alendronate on bone density and biochemical markers of bone remodeling in postmenopausal women with osteoporosis. , 2002, The Journal of clinical endocrinology and metabolism.

[14]  Fran Harris,et al.  Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs. , 2002, The American journal of medicine.

[15]  D. Black,et al.  Relationships Between Bone Mineral Density and Incident Vertebral Fracture Risk with Raloxifene Therapy , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  E. Siris,et al.  Importance of precision in bone density measurements. , 2001, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[17]  S. Cummings,et al.  Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. , 1999, Arthritis and rheumatism.

[18]  N. Binkley,et al.  Official positions of the International Society for Clinical Densitometry. , 2004, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[19]  G. Blake,et al.  Long-Term Precision of DXA Scanning Assessed over Seven Years in Forty Postmenopausal Women , 2000, Osteoporosis International.

[20]  P. Miller,et al.  Antifracture efficacy of antiresorptive agents are related to changes in bone density. , 2000, The Journal of clinical endocrinology and metabolism.

[21]  P. Miller,et al.  Clinical Application of Bone Densitometry , 1998 .